Entera Bio (ENTX) News
NASDAQ: ENTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
ENTX news summary
We found 1 recent headline mentioning Entera Bio (ENTX): 1 in the past week and 1 in the past 30 days, most often from GlobeNewswire. ENTX is making an outsized move today, up 6.40% at $2.66, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Entera Bio Announces Additional Presentation of EB613 Phase 3 Study Design at the ASBMR 2026 Annual Meeting", was published by GlobeNewswire on Oct 8, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology